Skip to content
investormap

Seaya Andromeda

Heal Capital · Venture capital

RollingLast verified 7 Nov 2026

Seaya Andromeda is a €300M European Article 9 climate tech fund investing €7M to €40M in Series A through Series C post-revenue companies across energy, industry, real estate, circular economy, and agrifood.

5 deals in the last 24 months, latest 12 May 2026. From its website and its deals in the news.

Key facts

Stages
Pre-seed, Seed, Series A, Series B, Series C+
Sectors
Climate & energy, Industrial & manufacturing, Proptech & construction, Circular economy, Foodtech, Agrifood
Ticket
€7M–€40M
Typical round size
€7.6M (median of its recent deals, not a ticket)
Leads rounds
25% of recent deals with a known role
Eligible countries
Not stated
Provider based in
Spain
Timing
Rolling applications
Focus
climatetech reducing CO2 or waste; energytech; post-revenue
Does not invest in
pre-revenue moonshots; nuclear fusion
How to apply
Apply route unknown

Recent deals

Deals in the last 24 months
CompanyRoundSectorsAmountRoleAnnounced
DittoSeedAI & machine learning, Healthtech, Consumer apps€7.6Mlead12 May 2026
ApherisSeries AB2B SaaS, Healthtech, Biotech & pharma€20.1Mparticipant14 Aug 2025
CGC Genomics · SwitzerlandPre-seedBiotech & pharma€1.7M–16 Apr 2025
ApherisSeedAI & machine learning€8.7Mparticipant24 Mar 2025
Apheris AISeries A€7.4Mparticipant28 Jan 2025

Evidence

Short excerpts from the sources, in their original language, that back the facts above.

Status history

  • 7 Nov 2026: Uncertain → Rolling (profiles: investor activity)
  • 7 Nov 2026: Rolling → Uncertain (freshness: investor activity)
  • 6 Nov 2026: Rolling (first extraction)

Something wrong or out of date? Report an error.

Work at Heal Capital? Claim this profile to confirm what you invest in.